208 related articles for article (PubMed ID: 33846410)
21. Epigenomic characterization of Clostridioides difficile finds a conserved DNA methyltransferase that mediates sporulation and pathogenesis.
Oliveira PH; Ribis JW; Garrett EM; Trzilova D; Kim A; Sekulovic O; Mead EA; Pak T; Zhu S; Deikus G; Touchon M; Lewis-Sandari M; Beckford C; Zeitouni NE; Altman DR; Webster E; Oussenko I; Bunyavanich S; Aggarwal AK; Bashir A; Patel G; Wallach F; Hamula C; Huprikar S; Schadt EE; Sebra R; van Bakel H; Kasarskis A; Tamayo R; Shen A; Fang G
Nat Microbiol; 2020 Jan; 5(1):166-180. PubMed ID: 31768029
[TBL] [Abstract][Full Text] [Related]
22.
Coullon H; Rifflet A; Wheeler R; Janoir C; Boneca IG; Candela T
J Biol Chem; 2018 Nov; 293(47):18040-18054. PubMed ID: 30266804
[TBL] [Abstract][Full Text] [Related]
23. Development of a Dual-Fluorescent-Reporter System in Clostridioides difficile Reveals a Division of Labor between Virulence and Transmission Gene Expression.
Donnelly ML; Shrestha S; Ribis JW; Kuhn P; Krasilnikov M; Alves Feliciano C; Shen A
mSphere; 2022 Jun; 7(3):e0013222. PubMed ID: 35638354
[TBL] [Abstract][Full Text] [Related]
24. Butyrate enhances
Baldassare MA; Bhattacharjee D; Coles JD; Nelson S; McCollum CA; Seekatz AM
J Bacteriol; 2023 Sep; 205(9):e0013823. PubMed ID: 37655912
[TBL] [Abstract][Full Text] [Related]
25. Clostridioides difficile SinR' regulates toxin, sporulation and motility through protein-protein interaction with SinR.
Ciftci Y; Girinathan BP; Dhungel BA; Hasan MK; Govind R
Anaerobe; 2019 Oct; 59():1-7. PubMed ID: 31077800
[TBL] [Abstract][Full Text] [Related]
26. Fidaxomicin inhibits spore production in Clostridium difficile.
Babakhani F; Bouillaut L; Gomez A; Sears P; Nguyen L; Sonenshein AL
Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S162-9. PubMed ID: 22752866
[TBL] [Abstract][Full Text] [Related]
27. Phase-variable expression of pdcB, a phosphodiesterase, influences sporulation in Clostridioides difficile.
Dhungel BA; Govind R
Mol Microbiol; 2021 Nov; 116(5):1347-1360. PubMed ID: 34606654
[TBL] [Abstract][Full Text] [Related]
28. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
[TBL] [Abstract][Full Text] [Related]
29. Regulatory Role of Anti-Sigma Factor RsbW in Clostridioides difficile Stress Response, Persistence, and Infection.
Cheng JKJ; Đapa T; Chan IYL; MacCreath TO; Slater R; Unnikrishnan M
J Bacteriol; 2023 May; 205(5):e0046622. PubMed ID: 37098979
[TBL] [Abstract][Full Text] [Related]
30. Initiation of sporulation in Clostridium difficile: a twist on the classic model.
Edwards AN; McBride SM
FEMS Microbiol Lett; 2014 Sep; 358(2):110-8. PubMed ID: 24910370
[TBL] [Abstract][Full Text] [Related]
31. Cephamycins inhibit pathogen sporulation and effectively treat recurrent Clostridioides difficile infection.
Srikhanta YN; Hutton ML; Awad MM; Drinkwater N; Singleton J; Day SL; Cunningham BA; McGowan S; Lyras D
Nat Microbiol; 2019 Dec; 4(12):2237-2245. PubMed ID: 31406331
[TBL] [Abstract][Full Text] [Related]
32. Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism.
Pettit LJ; Browne HP; Yu L; Smits WK; Fagan RP; Barquist L; Martin MJ; Goulding D; Duncan SH; Flint HJ; Dougan G; Choudhary JS; Lawley TD
BMC Genomics; 2014 Feb; 15():160. PubMed ID: 24568651
[TBL] [Abstract][Full Text] [Related]
33. The Spore Coat Protein CotE Facilitates Host Colonization by Clostridium difficile.
Hong HA; Ferreira WT; Hosseini S; Anwar S; Hitri K; Wilkinson AJ; Vahjen W; Zentek J; Soloviev M; Cutting SM
J Infect Dis; 2017 Dec; 216(11):1452-1459. PubMed ID: 28968845
[TBL] [Abstract][Full Text] [Related]
34. A Revised Understanding of Clostridioides difficile Spore Germination.
Lawler AJ; Lambert PA; Worthington T
Trends Microbiol; 2020 Sep; 28(9):744-752. PubMed ID: 32781028
[TBL] [Abstract][Full Text] [Related]
35. The pH-responsive SmrR-SmrT system modulates
Wetzel D; Carter ZA; Monteiro MP; Edwards AN; Scharer CD; McBride SM
Infect Immun; 2024 Mar; 92(3):e0046123. PubMed ID: 38345371
[No Abstract] [Full Text] [Related]
36.
Zhu D; Sorg JA; Sun X
Front Cell Infect Microbiol; 2018; 8():29. PubMed ID: 29473021
[No Abstract] [Full Text] [Related]
37. The key sigma factor of transition phase, SigH, controls sporulation, metabolism, and virulence factor expression in Clostridium difficile.
Saujet L; Monot M; Dupuy B; Soutourina O; Martin-Verstraete I
J Bacteriol; 2011 Jul; 193(13):3186-96. PubMed ID: 21572003
[TBL] [Abstract][Full Text] [Related]
38. Clostridioides difficile spores stimulate inflammatory cytokine responses and induce cytotoxicity in macrophages.
Chiu PJ; Rathod J; Hong YP; Tsai PJ; Hung YP; Ko WC; Chen JW; Paredes-Sabja D; Huang IH
Anaerobe; 2021 Aug; 70():102381. PubMed ID: 34082120
[TBL] [Abstract][Full Text] [Related]
39. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
40. Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.
Theriot CM; Young VB
Gut Microbes; 2014; 5(1):86-95. PubMed ID: 24335555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
